These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 337764)

  • 21. A preliminary clinical trial of hydrocortisone-17-butyrate.
    Alexander S; Lyne C
    Br J Clin Pract; 1973 May; 27(5):177-9. PubMed ID: 4585299
    [No Abstract]   [Full Text] [Related]  

  • 22. Topical corticosteroids: a comparison in the treatment of eczema and psoriasis in general practice.
    Marks JH; Garrett RT
    J R Coll Gen Pract; 1973 Mar; 23(128):225-7. PubMed ID: 4588474
    [No Abstract]   [Full Text] [Related]  

  • 23. A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
    Jemec GB; Ganslandt C; Ortonne JP; Poulin Y; Burden AD; de Unamuno P; Berne B; Figueiredo A; Austad J
    J Am Acad Dermatol; 2008 Sep; 59(3):455-63. PubMed ID: 18694678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metosyn--a new steroid for topical use.
    Meenan FO
    J Ir Med Assoc; 1972 Feb; 65(4):89-90. PubMed ID: 4259392
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of short-course class 1 topical glucocorticoid under occlusion for the rapid control of erythrodermic psoriasis.
    Arbiser JL; Grossman K; Kaye E; Arndt KA
    Arch Dermatol; 1994 Jun; 130(6):704-6. PubMed ID: 8002640
    [No Abstract]   [Full Text] [Related]  

  • 26. Betamethasone dipropionate and salicylic acid lotion for nonscalp dermatoses.
    Malfitan VA
    Clin Ther; 1983; 5(3):290-8. PubMed ID: 6850723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Augmented betamethasone: efficacy in psoriasis with different dosing frequencies.
    Singh S
    Arch Dermatol; 1996 Dec; 132(12):1525-6. PubMed ID: 8961896
    [No Abstract]   [Full Text] [Related]  

  • 28. Long-term use of Sicorten ointment in chronic recalcitrant dermatoses.
    Bellandini R; Martina G; Cambiaghi G; Casoni P; Santini R; Csermely E
    Br J Clin Pract; 1984; 38(11-12):395-8. PubMed ID: 6397220
    [No Abstract]   [Full Text] [Related]  

  • 29. Concurrent application of tretinoin (retinoic acid) partially protects against corticosteroid-induced epidermal atrophy.
    McMichael AJ; Griffiths CE; Talwar HS; Finkel LJ; Rafal ES; Hamilton TA; Voorhees JJ
    Br J Dermatol; 1996 Jul; 135(1):60-4. PubMed ID: 8776360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Halometasone cream by day and halometasone ointment at night for the treatment of patients with chronic psoriasis vulgaris.
    Galbiati G; Bonfacini V; Candiani F
    J Int Med Res; 1983; 11 Suppl 1():31-3. PubMed ID: 6339290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 1% pimecrolimus, 0.005% calcipotriol, and 0.1% betamethasone in the treatment of intertriginous psoriasis: a double-blind, randomized controlled study.
    Kreuter A; Sommer A; Hyun J; Bräutigam M; Brockmeyer NH; Altmeyer P; Gambichler T
    Arch Dermatol; 2006 Sep; 142(9):1138-43. PubMed ID: 16983001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amcinonide vs. betamethasone dipropionate ointments in the treatment of psoriasis.
    Huntley AC; Isseroff R
    Cutis; 1985 May; 35(5):489-92. PubMed ID: 3891239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A controlled clinical trial of a new formulation of betamethasone dipropionate cream in once-daily treatment of psoriasis.
    Ellis CN; Katz HI; Rex IH; Shavin JS; Van Scott EJ; VanderPloeg D
    Clin Ther; 1989; 11(6):768-74. PubMed ID: 2692821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Periodic application of topical corticosteroids. Practicability and therapeutic value in daily practice].
    Schmitz H; Flinzer E
    Derm Beruf Umwelt; 1982; 30(5):153-8. PubMed ID: 6818014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical double blind test with flupamesone and halcinonide].
    Ferrandiz Arjonilla L
    Rev Clin Esp; 1978 Jun; 149(5):495-7. PubMed ID: 358318
    [No Abstract]   [Full Text] [Related]  

  • 36. Correlation of the vasoconstriction assay and clinical activity in psoriasis.
    Cornell RC; Stoughton RB
    Arch Dermatol; 1985 Jan; 121(1):63-7. PubMed ID: 3881088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of treatment with Sicorten cream by day and Sicorten ointment at night in patients with chronic psoriasis.
    Feurman EJ; Yawalkar SJ
    Singapore Med J; 1986 Jun; 27(3):236-8. PubMed ID: 3764460
    [No Abstract]   [Full Text] [Related]  

  • 38. Double-blind clinical comparisons of topical betamethasone valerate and betamethasone benzoate in the treatment of steroid-responsive dermatoses.
    Hall-Smith P
    Br J Clin Pract; 1972 Sep; 26(9):422-3. PubMed ID: 4562674
    [No Abstract]   [Full Text] [Related]  

  • 39. Topical therapy for psoriasis with the use of augmented betamethasone and calcipotriene on alternate weeks.
    Singh S; Reddy DC; Pandey SS
    J Am Acad Dermatol; 2000 Jul; 43(1 Pt 1):61-5. PubMed ID: 10863225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Halcinonide, a new topical anti-inflammatory steroid.
    Savin RC
    J Int Med Res; 1976; 4(1):34-6. PubMed ID: 799976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.